Unbound MEDLINE

Treatment-resistant medication overuse headache can be cured.

Abstract

OBJECTIVE
To evaluate the long-term efficacy of a structured, multidisciplinary treatment program in patients who had been treated unsuccessfully for medication overuse headache by specialists in an open-label design.
BACKGROUND
Medication overuse headache is a common and disabling disease. Management is complicated by substantial treatment failure and relapse, and those who relapse and nonresponders to treatment are often excluded from studies on medication overuse headache.
METHODS
Patients with medication overuse headache who had previously been unsuccessfully treated by specialists and referred to a specialized, tertiary headache centre were recruited. They underwent a structured 2-month detoxification program and were subsequently closely followed up for 10 months by a multidisciplinary team of physicians, nurses, physiotherapists, and psychologists.
RESULTS
Eighty-six of 98 patients completed the study.
PRIMARY OUTCOME
At 12-month follow-up, headache frequency was reduced by 39.3% (P < .001), 71 patients (82.6%) remained cured of medication overuse, reduction in headache frequency of more than 50% occurred in 42 patients (48.8%), and 52 (60.5%) reverted to episodic headache. Both of these figures had increased significantly from month 2 to month 12 (P < .001). Medication use was reduced by 62.8% (P < .001).
CONCLUSION
Patients with medication overuse headache previously regarded treatment-resistant benefit considerably from multidisciplinary treatment in a structured detoxification program with close follow-up.

Links

  • Publisher Full Text
  • Authors

    Munksgaard SB, Bendtsen L, Jensen RH

    Institution

    Danish Headache Centre, Department of Neurology, Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen, Nordre Ringvej 57, Glostrup, Denmark.

    Source

    Headache 52:7 pg 1120-9

    MeSH

    Adolescent
    Adult
    Aged
    Analgesics
    Delivery of Health Care, Integrated
    Drug Resistance
    Female
    Follow-Up Studies
    Headache Disorders, Secondary
    Humans
    Incidence
    Male
    Metabolic Detoxication, Drug
    Middle Aged
    Nurses
    Physical Therapists
    Physicians
    Psychology
    Treatment Outcome
    Young Adult

    Pub Type(s)

    Clinical Trial
    Journal Article

    Language

    eng

    PubMed ID

    22724425